Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
21 nov. 2022 18h30 HE
|
Aridis Pharmaceuticals, Inc.
Top-line data from the Phase 3 clinical trial evaluating AR-301 for the treatment of VAP expected in December of this year LOS GATOS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aridis...